According to a recent LinkedIn post from ABM Respiratory Care, the company is exhibiting its BiWaze platform at the Mississippi Society for Respiratory Care meeting in Raymond, Mississippi, on March 5–6. The post highlights live, hands-on demonstrations of the BiWaze Cough and BiWaze Clear airway clearance systems and an educational CRCE session on oscillating lung expansion therapy.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post suggests ABM is positioning its BiWaze technology as an advanced solution for airway clearance, emphasizing features such as dual blower bi-directional control and a closed breathing circuit aimed at improved mucus mobilization and aerosol deposition. For investors, this presence may indicate a push to increase clinical engagement and adoption among respiratory therapists, potentially supporting future revenue growth in hospital and home-care respiratory markets.
By participating in a specialized professional conference and offering continuing education content, ABM appears to be targeting key clinical decision-makers who influence device selection. This strategy could help strengthen brand recognition, support real-world validation of its technology, and enhance competitiveness versus established respiratory care device manufacturers.
The inclusion of links for remote demos and further information also points to an effort to scale commercial outreach beyond the conference itself. If these initiatives convert into broader clinical uptake and recurring equipment and consumables demand, they could contribute to a more durable revenue base in the respiratory care segment.